Latest filing published 07 Oct 2025 for scPharmaceuticals Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Rachael Nokes appears in our data through filings on scPharmaceuticals Inc. shares, published by SEC (Form 4). Over a trading history stretching from 25 February 2020 to 7 October 2025, the count stands at 8 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 7 October 2025: a transaction, in scPharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations